Cargando…
Hydroxamic acid – A novel molecule for anticancer therapy
Hydroxamic acid is a potent moiety not only in the field of cancer therapy but also as a mutagenic agent. Among the various derivatives of hydroxamic acid, SAHA (Suberoylanilide Hydroxamic Acid) is considered as a potent anticancer agent. Scientists from the different corner synthesized different hy...
Autores principales: | Pal, Dilipkumar, Saha, Supriyo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401680/ https://www.ncbi.nlm.nih.gov/pubmed/22837956 http://dx.doi.org/10.4103/2231-4040.97281 |
Ejemplares similares
-
Chondroitin: a natural biomarker with immense biomedical applications
por: Pal, Dilipkumar, et al.
Publicado: (2019) -
Combination Therapy of Ledipasvir and Itraconazole in the Treatment of COVID-19 Patients Coinfected with Black Fungus: An In Silico Statement
por: Saha, Supriyo, et al.
Publicado: (2022) -
Suberoylanilide Hydroxamic Acid (SAHA) Is a Driver Molecule of Neuroplasticity: Implication for Neurological Diseases
por: Verrillo, Lucia, et al.
Publicado: (2023) -
Inhibition of glioblastoma cell proliferation, invasion, and mechanism of action of a novel hydroxamic acid hybrid molecule
por: Zhang, Issan, et al.
Publicado: (2018) -
α,ß-Didehydrosuberoylanilide hydroxamic acid (DDSAHA) as precursor and possible analogue of the anticancer drug SAHA
por: Chattopadhyay, Shital K, et al.
Publicado: (2019)